Gene · 1612
Papers4,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Key Genes Related to Immune Cells in Patients with COVID-19 Via Integrated Bioinformatics-Based Analysis. | Biochem Genet | 2023 | 37222960 | PubTator, text mining | PubMed |
| The genetic landscape and possible therapeutics of neurofibromatosis type 2. | Cancer Cell Int | 2023 | 37217995 | PubTator, text mining | PubMed |
| Distinct synaptic pools of DAPK1 differentially regulate activity-dependent synaptic CaMKII accumulation. | iScience | 2023 | 37216104 | PubTator, text mining | PubMed |
| Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy. | Explor Target Antitumor Ther | 2023 | 37205317 | PubTator, text mining | PubMed |
| Retraction: Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis. | PLoS One | 2023 | 37200305 | PubTator, text mining | PubMed |
Long non-coding RNA nuclear paraspeckle assembly transcript 1 downregulation protects lens epithelial cells from oxidative stress-induced apoptosis by regulating the microRNA-124-3p/death-associated protein kinase 1 axis in age-related cataract. | Int Ophthalmol | 2023 | 37191928 | PubTator, text mining | PubMed |
| Cyclooxygenase and Lipoxygenase Gene Expression in the Inflammogenesis of Colorectal Cancer: Correlated Expression of EGFR, JAK STAT and Src Genes, and a Natural Antisense Transcript, RP11-C67.2.2. | Cancers (Basel) | 2023 | 37190308 | PubTator, text mining | PubMed |
| Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts. | Cancers (Basel) | 2023 | 37190213 | PubTator, text mining | PubMed |
| Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance. | Cancers (Basel) | 2023 | 37190191 | PubTator, text mining | PubMed |
| Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy. | Biomedicines | 2023 | 37189787 | PubTator, text mining | PubMed |
Helicobacter pylori and Epstein-Barr Virus Co-Infection in Gastric Disease: What Is the Correlation with p53 Mutation, Genes Methylation and Microsatellite Instability in a Cohort of Sicilian Population? | Int J Mol Sci | 2023 | 37175810 | PubTator, text mining | PubMed |
| A Descriptive Whole-Genome Transcriptomics Study in a Stem Cell-Based Tool Predicts Multiple Tissue-Specific Beneficial Potential and Molecular Targets of Carnosic Acid. | Int J Mol Sci | 2023 | 37175790 | PubTator, text mining | PubMed |
| Epigenetic Alterations from Barrett's Esophagus to Esophageal Adenocarcinoma. | Int J Mol Sci | 2023 | 37175524 | PubTator, text mining | PubMed |
| The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors. | Cells | 2023 | 37174744 | PubTator, text mining | PubMed |
| Characterization of the molecular interactions between resveratrol derivatives and death-associated protein kinase 1. | FEBS J | 2023 | 37171222 | PubTator, text mining | PubMed |
| How autophagy, a potential therapeutic target, regulates intestinal inflammation. | Front Immunol | 2023 | 37168865 | PubTator, text mining | PubMed |
| Identifying E3 Ligase Substrates With Quantitative Degradation Proteomics. | Chembiochem | 2023 | 37166757 | PubTator, text mining | PubMed |
| Validation of lung cancer polygenic risk scores in a high-risk case-control cohort. | Genet Med | 2023 | 37154150 | PubTator, text mining | PubMed |
| Targeting HSF1 for cancer treatment: mechanisms and inhibitor development. | Theranostics | 2023 | 37153737 | PubTator, text mining | PubMed |
| Monitoring EGFR-lung cancer evolution: a possible beginning of a "methylation era" in TKI resistance prediction. | Front Oncol | 2023 | 37152062 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1612/papers?page=18